ClinicalTrials.gg

Cantero Therapeutics clinical trials

A subsidiary of BridgeBio

The registry lists 1 studies whose lead sponsor is Cantero Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 21, 2022.

Status

Completed
1

Phase

Phase 1
1

Where

United States
1

Registry sponsor names on this page

  • Cantero Therapeutics, a BridgeBio company1 study

Something wrong with this grouping? Tell us on the BridgeBio page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All BridgeBio studies →